Cargando…
Harmonization and standardization of biofluid‐based biomarker measurements for AT(N) classification in Alzheimer's disease
Fluid biomarkers are currently measured in cerebrospinal fluid and blood for Alzheimer's disease diagnosis and are promising targets for drug development and for patients’ follow‐up in clinical trials. These biomarkers have been grouped in an unbiased research framework, the amyloid (Aβ), tau,...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432775/ https://www.ncbi.nlm.nih.gov/pubmed/37600860 http://dx.doi.org/10.1002/dad2.12465 |